Cargando…

GINS2 is a novel prognostic biomarker and promotes tumor progression in early-stage cervical cancer

Mostrar otras versiones (1)

Detalles Bibliográficos
Autores principales:	Ouyang, Fei, Liu, Junling, Xia, Meng, Lin, Chuyong, Wu, Xianqiu, Ye, Liping, Song, Libing, Li, Jun, Wang, Jing, Guo, Peng, He, Mian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2021
Materias:	Corrigendum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8020209/ https://www.ncbi.nlm.nih.gov/pubmed/33882645 http://dx.doi.org/10.3892/or.2021.8016

Ejemplares similares

GINS2 is a novel prognostic biomarker and promotes tumor progression in early-stage cervical cancer
por: Ouyang, Fei, et al.
Publicado: (2017)

Epigenetic silencing of SALL2 confers tamoxifen resistance in breast cancer
por: Ye, Liping, et al.
Publicado: (2022)

Overexpression of HES6 has prognostic value and promotes metastasis via the Wnt/β-catenin signaling pathway in colorectal cancer
por: Xu, Yuandong, et al.
Publicado: (2022)

miR-1266 Contributes to Pancreatic Cancer Progression and Chemoresistance by the STAT3 and NF-κB Signaling Pathways
por: Zhang, Xin, et al.
Publicado: (2018)

Corrigendum to “Cell Cycle Genes Are Potential Diagnostic and Prognostic Biomarkers in Hepatocellular Carcinoma”
por: Liping, Xu, et al.
Publicado: (2020)

Corrigendum to “The SLC Family Are Candidate Diagnostic and Prognostic Biomarkers in Clear Cell Renal Cell Carcinoma”
por: Kang, Weiting, et al.
Publicado: (2020)

Identification of GINS1 as a potential prognostic biomarker for sarcoma using bioinformatic analysis
por: Zhao, Huanhuan, et al.
Publicado: (2023)

Corrigendum: Comparing progression biomarkers in clinical trials of early Alzheimer’s disease
Publicado: (2021)

Overexpression of Notch1 is associated with the progression of cervical cancer
por: Sun, Yan, et al.
Publicado: (2021)

Peculiar Gin Accident
por: Oliver, J. P.
Publicado: (1905)

TP53 and RET may serve as biomarkers of prognostic evaluation and targeted therapy in hepatocellular carcinoma
por: Ye, Song, et al.
Publicado: (2022)

Corrigendum to “Moderate Fluid Shear Stress Could Regulate the Cytoskeleton of Nucleus Pulposus and Surrounding Inflammatory Mediators by Activating the FAK-MEK5-ERK5-cFos-AP1 Signaling Pathway”
por: Ye, Dongping, et al.
Publicado: (2018)

Nuclear orphan receptor NR2F6 confers cisplatin resistance in epithelial ovarian cancer cells by activating the Notch3 signaling pathway
por: Li, Han, et al.
Publicado: (2019)

Corrigendum to “Sec23a mediates miR-200c augmented oligometastatic to polymetastatic progression” [EBioMedicine 37 (2018) 47–55]
por: Sun, Zhiwei, et al.
Publicado: (2021)

Corrigendum to “PLOD2 Is a Potent Prognostic Marker and Associates with Immune Infiltration in Cervical Cancer”
por: Li, Guang, et al.
Publicado: (2021)

A novel prognostic biomarker: GINS3 is correlated with methylation and immune escape in liver hepatocellular carcinoma
por: Lai, Tianqi, et al.
Publicado: (2023)

Expression and prognostic significance of TRPV6 in the development and progression of pancreatic cancer
por: Song, He, et al.
Publicado: (2022)

Perrone RD, Mouksassi M-S, Romero K, et al. Total kidney volume is a prognostic biomarker of renal function decline and progression to end-stage renal disease in patients with autosomal dominant polycystic kidney disease. Kidney Int Rep. 2017;2:442–450
Publicado: (2018)

Systematic review and meta-analysis of immunohistochemical prognostic biomarkers in resected oesophageal adenocarcinoma
por: Matthews, LH McCormick, et al.
Publicado: (2015)

ANP32E induces tumorigenesis of triple‐negative breast cancer cells by upregulating E2F1
por: Xiong, Zhenchong, et al.
Publicado: (2018)

Holland Gin as a Medicine
Publicado: (1852)

Rab22a is a novel prognostic marker for cell progression in breast cancer
por: He, Miao, et al.
Publicado: (2021)

Comprehensive Pan-Cancer Analysis of GINS2 for Human Tumour Prognosis and as an Immunological Biomarker
por: Meng, Wei, et al.
Publicado: (2022)

Corrigendum to “Claudin-1 Is a Valuable Prognostic Biomarker in Colorectal Cancer: A Meta-Analysis”
por: Zuo, Didi, et al.
Publicado: (2020)

miR-500a-3p is a Potential Prognostic Biomarker in Hepatocellular Carcinoma [Corrigendum]
Publicado: (2022)

A novel prognostic prediction model for recurrence in patients with stage II colon cancer after curative resection
por: Saso, Kazuhiro, et al.
Publicado: (2019)

Corrigendum: Amyloid and tau positive mild cognitive impairment: clinical and biomarker characteristics of dementia progression
Publicado: (2021)

Comprehensive analysis of GINS subunits prognostic value and ceRNA network in sarcoma
por: Zhou, Chuqiao, et al.
Publicado: (2022)

Corrigendum to “Evaluation of Plasma MicroRNAs as Diagnostic and Prognostic Biomarkers in Pancreatic Adenocarcinoma: miR-196a and miR-210 Could Be Negative and Positive Prognostic Markers, Respectively”
por: Yu, Qi, et al.
Publicado: (2018)

Corrigendum to “ARMCX Family Gene Expression Analysis and Potential Prognostic Biomarkers for Prediction of Clinical Outcome in Patients with Gastric Carcinoma”
por: Wang, TingAn, et al.
Publicado: (2021)

Jumonji AT-rich interactive domain 1B overexpression is associated with the development and progression of glioma
por: Fang, Liping, et al.
Publicado: (2016)

Molecular architecture of the human GINS complex
por: Boskovic, Jasminka, et al.
Publicado: (2007)

DNA replication: archaeal oriGINS
por: Bell, Stephen D
Publicado: (2011)

Prognostic Factors and Local Treatment Modalities of Small-Cell Carcinoma of the Cervix: An Analysis According to the International Federation of Gynecology and Obstetrics Stage [Corrigendum]
Publicado: (2020)

Corrigendum to: Treatment outcomes of patients with FIGO Stage I/II uterine cervical cancer treated with definitive radiotherapy: a multi-institutional retrospective research study
Publicado: (2016)

Overexpression of GINS4 Is Associated With Tumor Progression and Poor Survival in Hepatocellular Carcinoma
por: Zhang, Ziying, et al.
Publicado: (2021)

Corrigendum to “The novel putative methyltransferase METTL7A as one prognostic biomarker potentially associated with immune infiltration in human renal cancer”
por: Yang, Zhiqian, et al.
Publicado: (2023)

Circadian profiles in young people during the early stages of affective disorder
por: Naismith, S L, et al.
Publicado: (2013)

GINS4 might be a novel prognostic immune-related biomarker of not only esophageal squamous cell carcinoma and other cancers
por: Jin, Donghui, et al.
Publicado: (2022)

Identification of GINS2 prognostic potential and involvement in immune cell infiltration in hepatocellular carcinoma
por: Li, Zuyin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_upgqoge4s70mh0al11ub7rifii